• Treffer 2 von 4
Zurück zur Trefferliste

Synaptopathies: synaptic dysfunction in neurological disorders - a review from students to students

Zitieren Sie bitte immer diese URN: urn:nbn:de:bvb:20-opus-187509
  • Synapses are essential components of neurons and allow information to travel coordinately throughout the nervous system to adjust behavior to environmental stimuli and to control body functions, memories, and emotions. Thus, optimal synaptic communication is required for proper brain physiology, and slight perturbations of synapse function can lead to brain disorders. In fact, increasing evidence has demonstrated the relevance of synapse dysfunction as a major determinant of many neurological diseases. This notion has led to the concept ofSynapses are essential components of neurons and allow information to travel coordinately throughout the nervous system to adjust behavior to environmental stimuli and to control body functions, memories, and emotions. Thus, optimal synaptic communication is required for proper brain physiology, and slight perturbations of synapse function can lead to brain disorders. In fact, increasing evidence has demonstrated the relevance of synapse dysfunction as a major determinant of many neurological diseases. This notion has led to the concept of synaptopathies as brain diseases with synapse defects as shared pathogenic features. In this review, which was initiated at the 13th International Society for Neurochemistry Advanced School, we discuss basic concepts of synapse structure and function, and provide a critical view of how aberrant synapse physiology may contribute to neurodevelopmental disorders (autism, Down syndrome, startle disease, and epilepsy) as well as neurodegenerative disorders (Alzheimer and Parkinson disease). We finally discuss the appropriateness and potential implications of gathering synapse diseases under a single term. Understanding common causes and intrinsic differences in disease-associated synaptic dysfunction could offer novel clues toward synapse-based therapeutic intervention for neurological and neuropsychiatric disorders. In this Review, which was initiated at the 13th International Society for Neurochemistry (ISN) Advanced School, we discuss basic concepts of synapse structure and function, and provide a critical view of how aberrant synapse physiology may contribute to neurodevelopmental (autism, Down syndrome, startle disease, and epilepsy) as well as neurodegenerative disorders (Alzheimer's and Parkinson's diseases), gathered together under the term of synaptopathies. Read the Editorial Highlight for this article on page .zeige mehrzeige weniger

Volltext Dateien herunterladen

Metadaten exportieren

Weitere Dienste

Teilen auf Twitter Suche bei Google Scholar Statistik - Anzahl der Zugriffe auf das Dokument
Metadaten
Autor(en): Katarzyna Lepeta, Mychael V. Lourenco, Barbara C. Schweitzer, Pamela V. Martino Adami, Priyanjalee Banerjee, Silvina Catuara-Solarz, Mario de la Fuente Revenga, Alain Marc Guillem, Mouna Haider, Omamuyovwi M. Ijomone, Bettina Nadorp, Lin Qi, Nirma D. Perera, Louise K. Refsgaard, Kimberley M. Reid, Mariam Sabbar, Arghyadip Sahoo, Natascha Schaefer, Rebecca K. Sheean, Anna Suska, Rajkumar Verma, Cinzia Vicidomini, Dean Wright, Xing-Ding Zhang, Constanze Seidenbecher
URN:urn:nbn:de:bvb:20-opus-187509
Dokumentart:Artikel / Aufsatz in einer Zeitschrift
Institute der Universität:Medizinische Fakultät / Institut für Klinische Neurobiologie
Sprache der Veröffentlichung:Englisch
Titel des übergeordneten Werkes / der Zeitschrift (Englisch):Journal of Neurochemistry
Erscheinungsjahr:2016
Band / Jahrgang:138
Heft / Ausgabe:6
Seitenangabe:785-805
Originalveröffentlichung / Quelle:Journal of Neurochemistry (2016) 138:6, 785-805. https://doi.org/10.1111/jnc.13713
DOI:https://doi.org/10.1111/jnc.13713
Allgemeine fachliche Zuordnung (DDC-Klassifikation):6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Freie Schlagwort(e):Alpha-synuclein oligomers; Alzheimer disease; Amyloid-beta oligomers;; Autism spectrum disorders; Cellular prion protein; Central nervous system; Dentate granule cells; Down syndrome; Familial Alzheimers-disease; Inhibitory glycine receptor; P75 Neurotrophin receptor; Temporal-lobe epilepsy; autism; epilepsy; hyperekplexia; synapses
Datum der Freischaltung:16.06.2020
Lizenz (Deutsch):License LogoCC BY-NC-ND: Creative-Commons-Lizenz: Namensnennung, Nicht kommerziell, Keine Bearbeitungen 4.0 International